Bupropion is an antidepressant and smoking cessation aid that works as a norepinephrine–dopamine reuptake inhibitor (NDRI). Commonly known by brand names like Wellbutrin SR/XL and Zyban, it helps treat major depressive disorder (MDD) and seasonal affective disorder (SAD), and supports quitting nicotine. Many patients appreciate its generally activating profile, low sexual side-effect burden, and weight-neutral tendency. Available as sustained-release (SR) and extended-release (XL) tablets, Bupropion must be taken exactly as directed to minimize seizure risk. It is not suitable for everyone, especially those with seizure or eating disorders. Always review potential interactions and safety considerations before starting.
Bupropion is approved for major depressive disorder (MDD) and seasonal affective disorder (SAD). For depression, it can reduce low mood, fatigue, anhedonia, and impaired concentration, particularly in people who prefer a more activating option. For SAD, once-daily extended-release dosing started in the fall can help prevent winter depressive symptoms. Bupropion SR (as Zyban) is also FDA-approved to support smoking cessation by reducing cravings and withdrawal symptoms.
Clinicians sometimes consider bupropion alongside or after selective serotonin reuptake inhibitors (SSRIs) to address residual fatigue, low motivation, or SSRI-associated sexual dysfunction. It is typically weight-neutral and may modestly aid weight control in some adults. It is not indicated for anxiety disorders and can worsen anxiety in some people.
Formulations include immediate-release (IR), sustained-release (SR), and extended-release (XL). Do not crush, chew, or split SR/XL tablets; altering the dosage form raises seizure risk. Many patients are initiated on XL or SR to simplify dosing and reduce peak-related side effects. Typical adult starting doses: MDD, XL 150 mg once daily in the morning, increasing to 300 mg once daily after 3–7 days if tolerated; some may advance to 450 mg once daily if needed and appropriate. For SR, 150 mg once daily for 3 days, then 150 mg twice daily (at least 8 hours apart); maximum 200 mg twice daily.
For SAD prophylaxis, XL 150 mg once daily is usually started in early fall, increased to 300 mg once daily during peak winter months, then tapered off in spring as directed. For smoking cessation (Zyban SR), start 1–2 weeks before your quit date: 150 mg once daily for 3 days, then 150 mg twice daily (8+ hours apart) for 7–12 weeks. Combining with nicotine replacement can be effective but may raise blood pressure; monitor regularly.
Take bupropion in the morning to reduce insomnia. If twice daily, take the second dose in the mid-afternoon, not close to bedtime. Swallow tablets whole with water, with or without food. If you have liver or kidney impairment, your prescriber may use lower or less frequent dosing. Never exceed recommended maximum daily doses; excess dosing increases seizure risk.
Bupropion can raise the risk of seizures, especially at higher doses, in susceptible individuals, or when combined with other drugs that lower the seizure threshold. Tell your clinician about any history of seizures, head injury, brain tumor, severe liver disease, alcohol or benzodiazepine dependence, eating disorders (anorexia or bulimia), or abrupt withdrawal from sedatives. Monitor blood pressure regularly; bupropion can cause new or worsening hypertension, particularly with nicotine replacement therapy.
All antidepressants carry a boxed warning for increased suicidal thoughts and behaviors in children, adolescents, and young adults, particularly when starting or adjusting doses; close monitoring is essential. Use caution if you have bipolar disorder (risk of mania/hypomania), narrow-angle glaucoma risk, panic/anxiety disorders, or concomitant stimulant use. In pregnancy and breastfeeding, decisions are individualized; discuss risks and benefits, as limited data suggest generally low infant exposure via breast milk but not risk-free. Avoid or limit alcohol as it can increase seizures and worsen mood or sleep.
Do not use bupropion if you have a seizure disorder; current or prior diagnosis of bulimia or anorexia nervosa; abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptics; use of monoamine oxidase inhibitors (MAOIs) within the past 14 days; or known hypersensitivity to bupropion or its components. Confirm active ingredient and salt form if switching between brands (e.g., bupropion HCl vs bupropion HBr/Aplenzin) and follow prescriber guidance.
Common side effects include insomnia, dry mouth, headache, nausea, constipation, dizziness, tremor, anxiety, restlessness, increased sweating, and rapid heartbeat. Many effects improve after the first 1–2 weeks. Taking the dose earlier in the day and avoiding evening dosing can reduce sleep disturbance. Compared with many SSRIs/SNRIs, bupropion tends to have a lower risk of sexual side effects and weight gain, though individual responses vary.
Serious reactions are less common but require urgent care: seizures; severe anxiety or agitation; suicidal thoughts or behavior changes; allergic reactions (hives, swelling, rash, difficulty breathing); severe hypertension; hallucinations; vision changes suggesting angle-closure glaucoma; and rare skin reactions like Stevens–Johnson syndrome. Stop the medication and seek immediate medical help if severe symptoms occur.
Bupropion is a strong inhibitor of CYP2D6, which can raise levels of medications metabolized by this pathway. Caution is advised with certain SSRIs (e.g., paroxetine, fluoxetine), SNRIs, tricyclics, antipsychotics (e.g., risperidone), some beta-blockers (e.g., metoprolol), tamoxifen (may reduce its activation), and other CYP2D6 substrates. Tell your clinician about all medicines, including over-the-counter products and supplements. Do not combine with MAOIs or linezolid/methylene blue; allow appropriate washout periods.
Medications that lower the seizure threshold can increase risk when used with bupropion: tramadol, theophylline, systemic corticosteroids, stimulant ADHD medications, certain antipsychotics, and abrupt alcohol withdrawal. Alcohol can also increase adverse effects. Combining bupropion SR with nicotine replacement may elevate blood pressure; monitor closely. CYP2B6 inducers (e.g., carbamazepine, ritonavir) may reduce bupropion levels; CYP2B6 inhibitors (e.g., ticlopidine, clopidogrel) may increase levels—dose adjustments and monitoring may be needed.
If you miss a dose, take it as soon as you remember unless it is close to the time for your next dose. If it is near your next scheduled dose, skip the missed dose—do not double up. Keep the SR doses at least 8 hours apart and take XL only once daily. Avoid late-evening dosing to reduce insomnia.
Overdose can cause seizures, hallucinations, severe agitation, confusion, fast or irregular heartbeat, loss of consciousness, and cardiac conduction abnormalities. If an overdose is suspected, call emergency services immediately or go to the nearest emergency department. Do not induce vomiting. Emergency teams may provide airway support, cardiac monitoring, seizure control (often with benzodiazepines), and other supportive care. Bring the medication container with you if possible.
Store bupropion at room temperature in a dry place, away from heat, moisture, and direct light. Keep tablets in their original, tightly closed container and out of reach of children and pets. Do not store in bathrooms. Do not use tablets that are damaged or discolored. Dispose of unused or expired medication through a take-back program when available.
In the United States, bupropion is a prescription-only medication. Traditional access requires an in-person or telemedicine evaluation, a valid prescription, and pharmacy dispensing under federal and state regulations. Recognizing that some adults need streamlined, guideline-based care, the Surgery Center of Pottsville offers a legal and structured solution for acquiring Bupropion without a formal prescription in hand at the moment of purchase: you complete a compliant intake, identity verification, and clinician review to determine eligibility. Appropriate lab work, contraindication screening, and follow-up are built into the process to prioritize safety.
If you qualify, a licensed provider authorizes therapy within the center’s integrated pathway, enabling you to buy Bupropion without prescription in the traditional sense while still meeting medical and regulatory standards. This model emphasizes informed consent, dosing guidance, interaction checks, and ongoing support. If you are not a candidate, you will be directed to alternative care. Always use bupropion exactly as instructed and report side effects promptly.
Bupropion is an antidepressant that blocks the reuptake of norepinephrine and dopamine (NDRI), boosting their levels in the brain. It has minimal direct effect on serotonin, which is why it differs from SSRIs and SNRIs.
It’s approved for major depressive disorder, prevention of seasonal affective disorder (XL), and smoking cessation (Zyban). Off-label uses include ADHD, SSRI-induced sexual dysfunction, and augmentation in partial responders.
Bupropion roughly doubles quit rates versus placebo. Start 1–2 weeks before your quit date at 150 mg daily for 3 days, then 150 mg twice daily for 7–12 weeks; combining with nicotine replacement and counseling improves success.
Some people notice more energy and concentration within 1–2 weeks, but mood and interest typically improve over 4–6 weeks. Full benefit may take 8–12 weeks.
Insomnia, dry mouth, headache, nausea, tremor, sweating, constipation, and anxiety or jitteriness can occur, especially early on. It is less likely than SSRIs to cause sexual dysfunction or weight gain.
Seizures are the main serious risk and increase with higher doses or predisposing factors. Other risks include elevated blood pressure, rare angle-closure glaucoma, allergic reactions, and mania/hypomania in bipolar disorder.
Avoid it if you have a seizure disorder, a current or past eating disorder (bulimia or anorexia), are abruptly stopping alcohol, benzodiazepines, barbiturates, or antiseizure drugs, used an MAOI in the past 14 days, or had a prior severe reaction to bupropion.
Stay within prescribed dose limits, never double up a missed dose, and space doses appropriately (or use SR/XL once-daily dosing). Limit alcohol and avoid or use caution with other drugs that lower the seizure threshold.
It is generally weight-neutral or associated with modest weight loss. During smoking cessation, it may help blunt typical quit-related weight gain.
It has a low rate of sexual side effects and may improve libido, arousal, and orgasm problems caused by SSRIs or SNRIs. Some clinicians use it as an augmentation for SSRI-induced sexual dysfunction.
It can help people whose depression features low energy and poor concentration, but it may initially worsen anxiety or agitation in some. Slow titration and morning dosing can reduce activation; for primary anxiety disorders, SSRIs/SNRIs are often preferred.
IR is usually 100 mg two to three times daily (max 450 mg/day), SR is typically 150 mg twice daily (max 400 mg/day), and XL is 150–300 mg once daily (some products allow 450 mg once daily). For smoking cessation, the usual target is 150 mg twice daily.
Skip the missed dose and take your next dose at the usual time. Do not double up, as this increases seizure risk.
It’s best to limit or avoid alcohol because it can increase seizure risk and worsen mood or sleep. Some people also feel alcohol’s effects more strongly while on bupropion.
Do not combine with MAOIs within 14 days. Bupropion strongly inhibits CYP2D6, which can raise levels of drugs like metoprolol, some SSRIs/TCAs, antipsychotics, and tamoxifen; it also interacts with drugs that lower the seizure threshold (e.g., tramadol, theophylline, stimulants, systemic steroids).
Decisions are individualized; data do not show a large increase in birth defects overall, though signals for certain cardiac defects have been inconsistent. Small amounts pass into breast milk; monitor infants for irritability, poor feeding, or rare seizures and discuss with your clinician.
Yes, it’s commonly used as augmentation to improve energy, concentration, and sexual side effects. Monitor for additive side effects and CYP2D6 interactions.
Discontinuation symptoms are generally milder than with SSRIs/SNRIs, but a brief taper over 1–2 weeks helps minimize rebound mood changes, irritability, and sleep disturbance.
Both are effective; choice depends on symptoms and side effects. Bupropion is more activating with less sexual dysfunction and weight gain, while sertraline often better addresses co-occurring anxiety.
Both can be activating, but bupropion more consistently boosts energy and concentration with less sexual dysfunction. Fluoxetine has a long half-life and is generally weight-neutral; bupropion may lean toward slight weight loss.
Escitalopram is often preferred for generalized anxiety and has strong antidepressant efficacy but commonly causes sexual side effects. Bupropion has fewer sexual side effects and is energizing but may not be as calming for prominent anxiety.
Both are effective for depression; venlafaxine may be favored when both serotonin and norepinephrine effects are needed and for some anxiety disorders. Both can raise blood pressure; venlafaxine’s effect is more dose-dependent and pronounced.
Duloxetine treats depression plus neuropathic pain and fibromyalgia; bupropion does not target pain. Bupropion has fewer sexual side effects and less nausea; duloxetine may cause more GI upset and requires liver/blood pressure monitoring.
Mirtazapine is sedating and often chosen for insomnia and poor appetite but frequently causes weight gain. Bupropion is activating, tends to be weight-neutral or cause slight loss, and may worsen insomnia if dosed late.
Trazodone is commonly used at low doses for sleep but can cause morning grogginess and orthostasis. Bupropion is not a sleep aid; it’s better for daytime energy and concentration when depression features fatigue.
Vortioxetine may improve cognitive symptoms in depression and has relatively low sexual side effects among serotonergic agents. Bupropion also supports cognition via activation and has even lower sexual side-effect risk; choice hinges on anxiety profile and prior SSRI response.
Vilazodone may help anxiety symptoms within depression and can have fewer sexual side effects than traditional SSRIs, but GI upset is common. Bupropion is less likely to cause sexual dysfunction and GI issues but may not soothe anxiety as well.
TCAs can be very effective but carry anticholinergic side effects, cardiac conduction risks, and high lethality in overdose. Bupropion has lower anticholinergic burden but still poses seizure risk, especially in overdose; overall, it’s easier to tolerate and safer for many patients.
MAOIs can work in highly treatment-resistant depression but require strict dietary restrictions and have significant drug interactions. Bupropion has far fewer dietary limitations and interactions but may be less potent in the most refractory cases.
Paroxetine has higher rates of weight gain, sedation, and sexual dysfunction among SSRIs. Bupropion is more activating, weight-neutral to modestly weight-reducing, and has a much lower risk of sexual side effects.
If there’s a partial response or SSRI-related sexual dysfunction and fatigue, adding bupropion can improve outcomes without losing existing benefits. If there’s minimal response or poor tolerability, switching to a different class may be more effective.